Scott H. Goodnight

College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.

Michael Laposata, D Green, Elizabeth M. Van Cott et al. · PubMed · 1998 · 253 citations

Neurological disease associated with antiphospholipid antibodies

Dennis Briley, Bruce M. Coull, Scott H. Goodnight · Annals of Neurology · 1989 · 235 citations

Defibrination after Brain-Tissue Destruction

Scott H. Goodnight, Gayle Kenoyer, Samuel I. Rapaport et al. · New England Journal of Medicine · 1974 · 227 citations

Trauma Resuscitation, Traumatic Brain Injury, Brain Lesion +23

Failure of Antiplatelet and Anticoagulant Therapy to Improve Patency of Grafts after Coronary-Artery Bypass

George A. Pantely, Scott H. Goodnight, Shahbudin H. Rahimtoola et al. · New England Journal of Medicine · 1979 · 172 citations

Improve Patency, Pharmacotherapy, Surgery +20

An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases

Shirley B. Ingram, Scott H. Goodnight, Robert M. Bennett · Arthritis & Rheumatism · 1987 · 117 citations